Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Chromecki Thomas |

Präsentationen bei wissenschaftlichen Veranstaltungen

Linares Espinos, E; Martinez-Salamance, JI; Carballido, J; Gonzalez, J; Capitanio, U; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, W; Koppie, TM; Lorentz, A; Master, V; McKiernan, J; Montorsi, F; O'Malley, P; Pahernik, S; Palou, J; Pontones, JL; Pruthi, R; Rodriguez Faba, O; Russo, P; Scherr, DS; Spahn, M; Terrone, C; Tilki, D; Vazquez-Martul, D; Vera Donoso, C; Vergho, D; Wallen, E; Zigeuner, R; Libertino, J Impact of surgical volume on perioperative outcomes after nephrectomy with tumor thrombectomy
European Urology (suppl.). 2016; -31st Annual EAU Congress; MAR 11-15, 2016; Munich, GERMANY. [Poster]

 

Vazques Martul Pazos, D; Chantada, VC; Capitanio, U; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Gonzalez, J; Haferkamp, A; hohenfellner, M; Huang, WC; Koppie, TM; Linares Espinos, E; Lorentz, A; Martinez-Salamanca, JI; Mass, AY; Master, VA; McKiernan, JM; Montorsi, F; O'Malley, P; Pahernik, S; Palou, J; Pontones Moreno, JL; Pruthi, RS; Rodriguez Faba, O; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Vera Donoso, CD; Vergho, D; Wallen, EM; Zigeuner, R; Libertino, JA Preoperative renal artery embolisation in renal cell carcinoma with venous thrombus: preliminary results of a mulkticenter study
Eur Urol (suppl.). 2016; -31st Annual EAU Congress; MAR 11-15, 2016; Munich, GERMANY. [Poster]

 

Linares Espinos, E; Gonzales, J; Martinez-Salamanca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lascano, D; Lorentz, A; Mass, AY; Master, V; McKiernan, J; Mir, C; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Rodriguez-Faba, O; Russo, P; Scherr, D; Shariat, S; Spahn, M; Terrone, C; Tilki, D; Vergho, D; Wallen, E; Zigeuner, R; Libertino, JA A transplant-based surgical approach may improve postoperative complications in cases of renal cell carcinoma and tumor thrombus
J Urol (suppl.). 2015; 193(4):e982-e982.-AUA Annual Meeting; MAY 15-19,2015; New Orleans, USA. [Poster]

 

Meyer, C; Hansen, J; Becker, A; Schmid, M; Trinh, QD; Chromecki, T; Kainz, MC; Hutterer, G; Kampel-Kettner, K; Jesche, J; Fisch, M; Zigeuner, R; Chun, F Guideline-adapted use of nephron-sparing surgery for renal cell carcinoma - a confirmatory trend analysis over the last decade in two European referral centers
J Urol Suppl 2015;193(4):e878. 2015; -American Urological Association (AUA) Annual Meeting; May 15-19, 2015; New Orleans, LA, USA. [Poster]

 

Pak, JS; Lascano, D; Finkelstein, JB; McKiernan, JM; De Castro, GJ; Capitanio, U; Carballido, JA; Chantada, V; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, CP; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Linares Espinos, E; Lorentz, A; Martinez-Salamanca, JI; Martul, D; Mass, AY; Master, VA; Mir, C; Montorsi, F; Novara, G; O´Malley, P; Pahernik, S; Palou, J; Moreno, JLP; Pruthi, RS; Faba, OR; Russo, P; Scherr, DS; Shariat, SF; Spahn, M; Terrone, C; Tilki, D; Donoso, CV; Vergho, D; Wallen, EM; Zigeuner, R; Libertino, JA The Significance of Symptomatology: Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC)
J Urol (suppl.). 2015; 193(4):e533-e533.-AUA Annual Meeting; MAY 15-19,2015; New Orleans, USA. [Poster]

 

Bezan, A; Hutterer, G; Stöckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Gerger, A; Pummer, K; Zigeuner, R; Pichler, M; Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma partients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014. [Poster]

 

Bezan, A; Hutterer, GC; Stoeckigt, C; Chromecki, TF; Samonigg, H; Stojakovic, T; Pummer, K; Zigeuner, R; Pichler, M; A large scale validation study proposes high pre-operative plasma fibrinogen levels as an independent negative prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of renal cell carcinoma patients
ÖGHO Frühjahrstagung; APRIL 10-12, 2014; Innsbruck, AUSTRIA. 2014. [Poster]

 

Brookman-May, SD; Ficarra, V; Shariat, S; Zigeuner, R; Chromecki, T; Cindolo, L; Gunia, S; Aziz, A; Otto, W; Pahernik, S; Chun, F; Becker, A; Simeone, C; Longo, N; Zucchi, A; Stabiano, S; D'Alterio, C; Gilfrich, C; Schips, L; De Cobelli, O; Joniau, S; Waidelich, R; Pichler, M; Rocco, B; Tubaro, A; Feciche, B; Truss, M; Dalpiaz, O; Zastrow, S; Wirth, M; Santiago Martin, M; Hoschke, B; Stief, C; May, M Prognostic influence of chromophobe subtype and sarcomatoid dedifferentiation in patients with renal cell carcinoma and impact of clinical and histopathological parameters on disease-specific survival in patients with collecting duct renal cell carcinoma (CDRCC): Results of comprehensive analyses of the CORONA and SATURN databases and development of a disease-specific risk-model for CDRCC patients
Eur Urol Suppl 2014. 2014; 13(1):e317-e317.-29th Annual EAU Congress; APR 11-15, 2014; Stockholm, SWEDEN. [Poster]

 

Brookman-May, SD; Zigeuner, R; Ficarra, V; Shariat, S; Chromecki, T; Cindolo, L; Schips, L; Gunia, S; Chun, F; Becker, A; Pahernik, S; Stief, C; Waidelich, R; May, M Prognostischer Einfluss klinischer und histopathologischer Parameter auf das krankheitsspezifische Überleben bei Patienten mit Duct-Bellini-Nierenzellkarzinom (CDRCC) – Entwicklung eines krankheitsspezifischen Risikomodells und Untersuchung immunhistochemischer Marker zur pathologischen differenzialdiagnostischen Abgrenzung dieser Tumorentität
Der Urologe Suppl. 2014; 53(1):116-116.-66. Kongress der Deutschen Gesellschaft für Urologie e.V.; OCT 1-4, 2014; Düsseldorf, GERMANY. [Oral Communication]

 

Linares, E; Martínez-Salamanca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; González, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lorentz, A; Martínez Ballesteros, C; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodríguez-Faba, O; Russo, P; Spahn, M; Shariat, S; Terrone, C; Tilki, D; Vergho, D; Volpe, A; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, JA Cancer-specific survival and predictors in patients with cT3b kidney cancer: data of the IRCVT RCC venous thrombus consortium
Journal of Urology, suppl., Abstract: MP57-12 . 2014; -AUA Annual Meeting 2014; MAY 16-21, 2014; Orlando, FL, USA. [Poster]

 

Nguyen, H; Tilki, D; Dall'Era, M; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, W; Koppie, T; Lorentz, A; Mandel, P; Martinez-Salamanca, J; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, S; Spahn, M; Terrone, C; Vergho, D; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, J; Evans, C Does the use of cardiopulmonary by-pass (CPB) impact survival in patients undergoing nephrectomy/level III-IV tumor thrombectomy? A multi-institutional analysis
Journal of Urology, MP57-11. 2014; -AUA Annual Meeting 2014; Mai 16-21 2014; Orlando, FL, USA. [Poster]
FullText

 

Rodríguez Faba, O; Martínez Salamanca, JI; Tilki, D; Dall'Era, MA; Nguyen, HG; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Hu, B; Gontero, P; Turin, González, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, A; Mandel, P; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Pruthi, RS; Ramaswamy, K; Paul Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans,CP; Palou, J; Impact of microscopic vein invasion on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus
Journal of Urology, MP30-13 . 2014; -AUA Annual Meeting 2014; Mai 16-21 2014; Orlando, FL, USA. [Poster]
FullText

 

Seles, M;Mayrhofer, K; Chromecki, T; Augustin, H; Pummer K Wieso blutet das noch immer - Fallpräsentation einer ungewöhnlichen Makrohämaturie
Urocyclikum 2014; OKT 17-19,2014; St. Wolfgang. 2014. [Oral Communication]

 

Tilki, D; Hu, B; Nguyen, H; Dall'Era, M; Thieu, W; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, W; Koppie, T; Lorentz, A; Mandel, P; Martinez-Salamanca, J; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, S; Spahn, M; Terrone, C; Vergho, D; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, J; Evans, C Impact of synchronous metastasis distribution on survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy
Eur Urol Suppl. 2014; 13(1):e1043-e1043.-29th Annual EAU Congress; APR 11-15, 2014; Stockholm, SWEDEN. [Poster]

 

Aziz, A; May, M; Zigeuner, R; Chromecki, T; Cindolo, L; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Tubaro, A; Coman, I; Truss, M; Dalpiaz, O; Hoschke, B; Gilfrich, C; Feciche, B; Fenske, F; Fritsche, HM; Figenshau, RS; Madison, K; Sánchez-Chapado, M; del Carmen Santiago Martin, M; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, C; Brookman-May, S Weisen junge Patienten mit operiertem Nierenzellkarzinom eine distinkte Prognose auf? Eine komparative Analyse an Patienten unter 40 Jahren im Vergleich zu Patienten im 7. Lebensjahrzehnt auf der Basis der multinationalen CORONA-Datenbank
German Medical Science GMS Publishing House DOI: 10.3205/13oegu060 . 2013; -39. gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; JUN 6-8, 2013; Graz, AUSTRIA. [Poster]
FullText

 

Brookman-May, S; Gunia, S; Chromecki, T; Zigeuner, R; Dalpiaz, O; Gilfrich, C; Stief, C; Waidelich, R; Pahernik, S; Zastrow, S; Wirth, M; May, M Prognostischer Einfluss der sarkomatoiden Dedifferenzierung bei Patienten mit operativ therapiertem Nierenzellkarzinom - Ergebnisse einer Matched-Pair-Analyse der multizentrischen CORONA-Datenbank
German Medical Science GMS Publishing House DOI: 10.3205/13oegu069 . 2013; -39. gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; JUN 6-8, 2013; Graz, AUSTRIA. [Poster]

 

Brookman-May, S; May, M; Aziz, A; Chromecki, T; Dalpiaz, O; Gilfrich, C; Waidelich, R; Stief, C; Zigeuner, R Geschlechtsspezifische Unterschiede in klinischen und pathologischen Parametern sowie im Überleben von operativ therapierten Nierenzellkarzinom-Patienten - Eine Analyse der multizentrischen CORONA-Datenbank
German Medical Science GMS Publishing House DOI: 10.3205/13oegu065 . 2013; -39. gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung; JUN 6-8, 2013; Graz, AUSTRIA. [Poster]
FullText

 

Brookman-May, S; May, M; Zigeuner, R; Aziz, A; Cindolo, L; Gilfrich, C; Schips, L; De Cobelli, O; Rocco, B; De Nuzio, C; Tubaro, A; Coman, I; Feciche, B; Truss, M; Hoschke, B; Dalpiaz, O; Stoltze, A; Fenske, F; Chromecki, T; Lebentrau, S; Figenshau, RS; Madison, K; Sanchez-Chapado, M; del Carmen Santiago Martin, M; Salzano, L; Lotrecchiano, G; Joniau, S; Waidelich, R; Stief, C Einfluß des chromophoben histologischen Subtyps, der sarkomatoiden Differenzierung und des Geschlechts auf die Prognose von Patienten mit operativ therapiertem Nierenzellkarzinom-Ergebnisse einer umfassenden Analyse der multizentrischen CORONA-Datenbank.
Der Urologe Supplement 1. 2013; 52: 20-20.-65. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 25-28, 2013; Dresden, GERMANY. [Oral Communication]

 

Hutterer, GC; Pichler, M; Stöckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R Validation of the pre-treatment neutrophil-lymphocyte ratio as prognostic factor regarding cancer-specific-, metastasis-free-, as well as overall survival in a European cohort of patients with renal cell carcinoma
Proceedings book of the 2013 Genitourinary Cancers Symposium;194. 2013; -2013 Genitourinary Cancers Symposium: A Transformative Multidisciplinary Approach; FEB 14-16, 2013; Orlando, FL. [Poster]

 

Hutterer, GC; Pichler, M; Stöckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R Hoher präoperativer Plasma-Fibrinogen-Spiegel als unabhängiger negativer Prognosefaktor bezüglich des krebsspezifischen, metastasenfreien und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center-Serie
Der Urologe Supplement 1. 2013; 52: 84-84.-65. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 25-28, 2013; Dresden, GERMANY. [Poster]

 

Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS
J UROLOGY. 2013; 189(4): E300-E301. [Poster]
Web of Science

 

Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R A large scale validation study proposes high pre-operative plasma fibrinogen levels as an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of renal cell carcinoma patients
Eur Urol Suppl. 2013;12;e347.. 2013; -28th Annual EAU (European Association of Urology) Congress ; 15-19 Mar, 2013; Milan, IT. [Poster]

 

Jesche, J; Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Gerger, A; Pummer, K; Zigeuner, R Evaluierung der Wertigkeit der präoperativen Neutrophilen-/Lymphozyten-Ratio als Prognosefaktor bezüglich des krebsspezifischen-, metastasenfreien- und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House; 2013. DOI:10.3205/13oegu061. 2013; -39. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung, Graz; 06.-08.06.2013; Graz. [Poster]

 

Jesche, J; Hutterer, GC; Pichler, M; Stoeckigt, C; Chromecki, TF; Stojakovic, T; Golbeck, S; Mannweiler, S; Pummer, K; Zigeuner, R Hoher präoperativer Plasma-Fibrinogen-Spiegel als unabhängiger negativer Prognosefaktor bezüglich des krebsspezifischen-, metastasenfreien- und Gesamtüberlebens von Nierenzellkarzinompatienten in einer europäischen Single-Center Serie
German Medical Science GMS Publishing House; 2013. DOI:10.3205/13oegu058. . 2013; -39. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie sowie der Bayerischen Urologenvereinigung; 06.-08.06.2013; Graz. [Poster]

 

Marti­nez-Salamanca, JI; Novara, G; Bertini, R; Carballido, J; Chromecki, T; Ciancio, G; Daneshmand, S; Evans, C; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, T; Lorentz, A; Martinez-Ballesteros, C; Master, V; Matloob, R; McKiernan, J; Mlynarczyk, C; Montorsi, F; Nguyen, H; Pahernik, S; Palou, J; Pruthi, R; Ramaswamy, K; Rodriguez-Faba, O; Russo, P; Spahn, M; Shariat, S; Terrone, C; Tilki, D; Vergho, D; Volpe, A; Wallen, E; Xylinas, E; Zigeuner, R; Libertino, JA Level of thrombus according to Mayo clinic classification is an independent predictor of perioperative complications and cancer-related outcome: data of the IRCVT RCC venous thrombus consortium
J Urol (suppl.). 2013; 189(4):e782-e782.-AUA Annual Meeting; MAY 4-8, 2013; Dan Diego, CA., USA. [Poster]

 

Roscigno, M; Shariat, S; May, M; Zigeuner, R; Chromecki, T; Stief, C; Schips, L; De Cobelli, O; Rocco, B; De Nunzio, C; Feciche, B; Truss, M; Pahernik, S; Zastrow, S; Novara, G; Minervini, A; Antonelli, A; Mirone, V; Simonato, A; Bertini, R; Ficarra, V; Brookman-May, S Independent validation of the 2010 TNM staging system for renal cell carcinoma: Does it improves predictive accuracy in cancer-specific mortality compared to 2002 TNM?
European Urology Supplements. 2013; 12(1):e340-e340.-28th Annual EAU Congress; MAR 15-19, 2013; Milan, ITALY. (ISBN: 978-90-79754-58-8 ) [Poster]

 

Tilki, D; Dall'Era, MA; Nguyen, HG; Bertini, R; Carballido, JA; Chromecki, T; Ciancio, G; Daneshmand, S; Gontero, P; Gonzalez, J; Haferkamp, A; Hohenfellner, M; Huang, WC; Koppie, TM; Lorentz, A; Martinez-Salamanca, JI; Master, VA; Matloob, R; McKiernan, JM; Mlynarczyk, CM; Montorsi, F; Novara, G; Pahernik, S; Palou, J; Pruthi, RS; Ramaswamy, K; Rodriguez Faba, O; Russo, P; Shariat, SF; Spahn, M; Terrone, C; Vergho, D; Wallen, EM; Xylinas, E; Zigeuner, R; Libertino, JA; Evans, CP Impact of histologic subtype on tumor thrombus level and cancer-specific survival in patients with renal cell carcinoma and vena cava thrombus
J Urol (suppl.). 2013; 189(4):e751-e752.-AUA Annual Meeting; MAY 4-8, 2013; San Diego, CA., USA. [Oral Communication]

 

Becker, A; Hansen, J; Eichelberg, C; Heuer, R; Adam, M; Meyer, C; Kampel-Kettner, K; Kainz, MC; Chromecki, T; Jesche, J; Zigeuner, R; Chun, F Ein vereinfachtes 2 oder 3 gradiges Fuhrman Grading System kann das krankheitsspezifische Überleben von an 2 grossen europäischen Kliniken operierten Patienten mit klarzelligem Nierenzellkarzinom ebenso exakt vorhersagen wie deas herkömmliche 4 gradige System.
Der Urologe (Supplement 1). 2012; 51(1):110-110.-64. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 26-29, 2012; Leipzig, GERMANY. [Poster]

 

Becker, A; Hansen, J; Eichelberg, C; Heuer, R; Meyer, CP; Adam, M; Kampel-Kettner, K; Kainz, MC; Chromecki, T; Jesche, J; Zigeuner, R; Chun, KHF A simplified 2 or 3 graded Fuhrman grading system for clear cell renal cell carcinoma could predict cancer-specific-survival as accurate as the traditional 4 graded system in patients from 2 tertiary care centers in Europe
EUR UROL SUPPL. 2012; 11(1): E1021-U136. [Poster]
Web of Science

 

Brookman-May, S; Burger, M; Chromecki, T; Gilfrich, C; Pahernik, S; Wieland, W; Wirth, MP; Zastrow, S; Zigeuner, R; Truss, M; Shariat, S; Ficarra, V; Cindolo, L; May, M Einfluß der rezidivfreien Überlebenszeit nach Nephrektomie und weiterer Kriterien auf das karzinomspezifische Überleben nach einem Tumorrezidiv für Patienten mit Nierenzellkarzinom
Der Urologe (Supplement 1). 2012; 51(1):110-110.-64. Kongreß der Deutschen Gesellschaft für Urologie e.V.; SEP 26-29, 2012; Leipzig, Germany. [Poster]

 

Brookman-May, S; Chromecki, T; Zigeuner, R; Burger, M; Gilfrich, C; Hohenfellner, M; Pahernik, S; Wieland, MF; Zastrow, S; Wirth, MPBrookman-Amissah, S; May, M Collecting System Invasion und Fuhrman Grading ermöglichen ermöglichen eine prognostische Stratifizierung von Patienten mit einem pT2 Nierenzellkarzinom, nicht jedoch die Tumorgröße. Kann die aktuelle 7. Edition der TNM-Klassifikation verbessert werden?
Der Urologe (Supplement 1). 2012; 51(1):110-110.-64. Kongreß der Deutschen Gesellschaft für Urologie e.V.; SEP 26-29, 2012; Leipzig, GERMANY. [Poster]

 

Brookman-May, S; May, M; Burger, M; Denzinger, S; Otto, W; Hoschke, B; Wieland, WF; Rossler, W; Wenzl, V; Kohlschreiber, S; Chromecki, T; Pahernik, S; Hohenfellner, M; Zigeuner, R Thrombocytosis is associated with a significant increase in cancer specific death rate after nephrectomy for patients with renal cell carcinoma
EUR UROL SUPPL. 2012; 11(1): E1019-U132. [Poster]
Web of Science

 

Brookman-May, S; Zigeuner, R; Chromecki, T; Shariat, SF; Burger, M; Aziz, A; Wieland, WF; Pahernik, S; Wirth, MP; Zastrow, S; Gilfrich, C; May, M Collecting System Invasion und Fuhrman Grading sind prognostisch stratifizieren bei Patienten mit einem pT2 Nierenzellkarzinom, die Tumorgröße jedoch nicht. Kann die aktuelle 7. Edition der TNM-Klassifikation für die Nierenzellkarzinome verbessert werden?
J Urol Urogynäkol. 2012; 19(2):21-21.-38. gemeinsame Tagung der Bayerischen Urolgenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; JUN 14-16, 2012; Nürnberg, GERMANY. [Poster]

 

Brookman-May, SD; May, M; Zigeuner, R; Chromecki, T; Shariat, SF; Burger, M; Wieland, WF; Cindolo, L; Wirth, MP; Pahernik, S; Zastrow, S Collecting system invasion and Fuhrman grading but not tumour size facilitate prognostic stratification of patients with pT2 renal cell carcinoma - can the current 7th edition of TNM classification be improved?
EUR UROL SUPPL. 2012; 11(1): E1015-U124. [Poster]
Web of Science

 

Fajkovic, H; Cha, EK; Jeldres, C; Donner, G; Chromecki, TF; Margulis, V; Giacomo, N; Lotan, Y; Raman, JD; Kassouf, W; Seitz, C; Bensalah, K; Weizer, A; Kikuchi, E; Roscigno, M; Remzi, M; Matsumoto, K; Breinl, E; Pycha, A; Ficarra, V; Montorsi, F; Scherr, D; Shariat, SF. Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma
EUR UROL SUPPL. 2012; 11(1):E552-U189. [Oral Communication]
Web of Science

 

Hutterer, GC; Pichler, M; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 TNM classification system regarding the prediction of metastasis-free survival in patients with renal cell carcinoma.
J Urol Suppl 2012;187(4S):E286 . 2012; -107th American Urological Association (AUA) Annual Meeting; MAY 19-23; Atlanta, GA, USA. [Poster]

 

Hutterer, GC; Pichler, M; Chromecki, TF; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Comparison of the 2002 and 2010 version of the TNM classification system regarding the prediction of metastasis-free survival in patients with renal cell carcinoma.
Proceedings book of the 2012 Genitourinary Cancers Symposium;179.. 2012; -2012 Genitourinary Cancers Symposium: Novel Mechanisms and Therapies in Multidisciplinary Management; FEB 2-4, 2012; San Francisco, CA. [Poster]

 

Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Validation of the 2002 and 2010 TNM classification systems for the prediction of metastasis-free and overall survival in renal cell carcinoma patients
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Pichler, M; Hutterer, G; Chromecki, T; Samonigg, H; Jesche, J; Kampel-Kettner, K; Pummer, K; Zigeuner, R Renal cell carcinoma stage migration in a single European center over 25 years: effects on 5 and 10 years metastasis-free survival
Frühjahrstagung der Österreichischen Gesellschaft für Hämatologie und Onkologie; APR 12-14, 2012; Graz, Austria. 2012. [Poster]

 

Pichler, M; Hutterer, GC; Chromecki, TF; Jesche, J; Groselj-Strele, A; Kampel-Kettner, K; Pummer, K; Zigeuner, R Prognostic Value of the Leibovich Prognosis Score Supplemented by Vascular Invasion for Clear Cell Renal Cell Carcinoma.
Workshop des FF-Krebsforschung; APR 23, 2012; Graz, Austria. [Oral Communication]

 

Cha, E; Chromecki, T; Sun, M; Svatek, R Prognostic tool to help identify pT1-3 N0 patients likely to benefit from adjuvant chemotherapy after radical cystectomy.
The Journal of Urology. 2011; 185(4):568-568.-American Urological Association (AUA) Annual Meeting; MAY 14-19, 2011; Washington DC. [Oral Communication]

 

Chromecki, T; Cha, E; Lee, D; Pummer, K; Tewari, A; Sooriakumaran, P; Ashfaq, R; Roehrborn, C; Karakiewicz, P; Shariat, S Prognostic value of insulin-like growth factor II mRNA binding protein 3 (IMP3) in prostate cancer.
Urology. 2011; 78(3):315-316.-31st Congress of the Société Internationale d'Urologie (SIU); OKT 16-20, 2011; Berlin, GERMANY. [Poster]

 

Chromecki, T; Cha, E; Lee, R; Karakiewicz, P; Novara, G; Zigeuner, R; Ng, C; Chun, F; Scherr D; Shariat, S Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
Urology. 2011; 78(3):224-225.-31st Congress of the Société Internationale d'Urologie (SIU); OKT 16-20, 2011; Berlin, GERMANY. [Poster]

 

Chromecki, T; Cha, E; Pummer, K; Scherr, D; Tewari, A; Sun, M; Fajkovic, H; Roehrborn, C; Ashfaq, R; Karakiewicz, P; Shariat, S Prognostic value of insulin-like growth factor II mRNA binding protein 3 (IMP3) in patients treated with radical prostatectomy.
The International Prostate Cancer Symposium; MAY 10-12, 2011; New York, US. 2011. [Oral Communication]

 

Chromecki, T; Cha, EK; Pummer, K; Shariat, SF CHRONOLOGICAL AGE IS NOT AN INDEPENDENT PREDICTOR OF CLINICAL OUTCOMES AFTER RADICAL NEPHROURETERECTOMY
J MENS HEALTH. . 2011; 8(3):216-217.-ISMH Congress 2011; [Poster]
Web of Science FullText FullText_MUG

 

Chromecki, T; Shariat, S; Svatek, R; Karakiewicz, P; Mazumdar, M; Dunning, A; Cha, E; Scherr, D; Sylvester, R Prognostic factors of cancer recurrence and progression in non-muscle-invasive urothelial carcinoma: A multicenter study of over 4,300 patients.
Proceedings book of the 2011 genitourinary cancer symposium. 2011; -ASCO Genitourinary Cancers Symposium; FEB 17-19, 2011; Florida, ORLANDO, USA. [Oral Communication]

 

Chromecki, T; Shariat, S; Svatek, R; Karakiewicz, P; Mazumdar, M; Dunning, A; Cha, E; Scherr D; Sylvester, R Prognostic factors of cancer recurrence and progression in patients with non-muscle-invasive urothelial carcinoma.
Eur Urol Suppl. 2011; 9(2):-26th Anniversary EAU (European Association of Urology) Congress; MAR 18-22, 2011; Vienna, AUSTRIA. [Oral Communication]

 

Dalpiaz, O; Hutterer, GC; Chromecki, TF; Zigeuner, R;Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M; Mannweiler,S Nachweis tumorassoziierter Makrophagen (TAM) als prognostisch günstiger Indikator bei Patienten mit papillärem Nierenzellkarzinom
Abstractband von 57. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie 2011. 2011; -57. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie; APR 14-16, 2011; Aachen, GERMANY. [Oral Communication]

 

Dalpiaz, O; Hutterer, GC; Chromecki, TF; Zigeuner, TF; Mannweiler, S; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M Externe Validierung eines Nomogrammes zur Vorhersage des karzinomspezifischen Überlebens bei Patienten mit papillärem Nierenzellkarzinom
Abstractband von 57. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie 2011. 2011; -57. Kongress der Nordrhein-Westfälischen Gesellschaft für Urologie; APR 14-16, 2011; Aachen, GERMANY. [Oral Communication]

 

Grover, S; Sooriakumaran, P; Srivastava, A; Shariat, SF; Rink, M; Chun, FK; Chromecki TF; Karakiewicz, PI; Novara, G; Montorsi, F; Slawin, KM; Nyberg, T; Carlsson, S; Nilsson, A; Wiklund, P; Lee, DI; Tewari, A Comparative oncologic effectiveness of open versus robotic-assisted radical prostatectomy in patients with extracapsular extension and/or seminal vesicle invasion.
J Urol. 2011; 185(4):263-264.-106th Annual Meeting of the American Urological Association (AUA); MAY 14-19, 2011; Washington DC, USA. [Oral Communication]

 

Hutterer, GC; Chromecki, TF; Zigeuner, R; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M; Mannweiler, S Evaluation of tumor-associated macrophages as a prognostic indicator in patients with papillary renal cell carcinoma.
Proceedings book of the 2011 Genitourinary Cancers Symposium;139.2011; 139-139.-Genitourinary Cancers Symposium: An Evidence-based Multidisciplinary Approach; FEB 17-19, 2011; Orlando, FL. [Poster]

 

Shariat, S; Cha, E; Chromecki, T; Chiu, Y, Rink, M; Lotan, Y; Novara, G; Svatek, R; Karakiewicz, P; Scherr, D Stage pT0 after radical cystectomy: are all patients equal?
Urology. 2011; 78(3):17-17.-31st Congress of the Société Internationale d'Urologie (SIU); OKT 16-20, 2011; Berlin, GERMANY. [Poster]

 

Shariat, S; Chromecki, T; Cha, E; Chun, F; Lotan, Y; Novara, G; Svatek, R; Karakiewicz, P; Scherr, D Risk stratification of patients who are pT0N0 after radical cystectomy ?
Urology. 2011; 78(3):17-18.-31st Congress of the Société Internationale d'Urologie (SIU); OKT 16-20, 2011; Berlin, GERMANY. [Poster]

 

Shariat, S; Chromecki, T; Hoefer, J; Barbieri, Ch Soluble gp130 affects prostate cancer invasion and progression in an IL-6-dependent and independent manner.
The Journal of Urology. 2011; 185(4):936-936.-American Urological Association (AUA) Annual Meeting; MAY 14-19, 2011; Washington DC. [Oral Communication]

 

Shariat, SF; Grover, S; Srivastava, A; Sooriakumaran, P; Lee, D; Rink, M; Chun, FK; Chromecki TF; Karakiewicz, PI; Novara, G; Montorsi, F; Slawin, KM; Nyberg, T; Carlsson, S; Nilsson, A; Wiklund, P; Lee, DI; Tewari, A Biochemical failure in D’Amico low risk patients with gleason sum upgrading following radical prostatectomy: an international, multi-institutional study.
J Urol. 2011; 185(4):484-484.-106th Annual Meeting of the American Urological Association (AUA); MAY 14-19, 2011; Washington DC, USA. [Oral Communication]

 

Sooriakumaran, P; Shariat, SF; Srivastava, A; Grover, S; Rink, M; Chun, FK; Chromecki TF; Karakiewicz, PI; Novara, G; Montorsi, F; Slawin, KM; Nyberg, T; Carlsson, S; Nilsson, A; Wiklund, P; Lee, DI; Tewari, A Comparative outcome analysis of open versus robotic-assisted radical prostatectomy matched by D’Amico risk category.
J Urol. 2011; 185(4):263-263.-106th Annual Meeting of the American Urological Association (AUA); MAY 14-19, 2011; Washington DC, USA. [Oral Communication]

 

Srivastava, A; Grover, S; Sooriakumaran, P; Shariat, SF; Rink, M; Chun, FK; Chromecki TF; Karakiewicz, PI; Novara, G; Montorsi, F; Slawin, KM; Nyberg, T; Carlsson, S; Nilsson, A; Wiklund, P; Lee, DI; Tewari, A Outcomes of open versus robotic-assisted radical prostatectomy for high-risk prostate cancer: a multi-institution study on 13,567 men.
J Urol. 2011; 185(4):142-142.-106th Annual Meeting of the American Urological Association (AUA); MAY 14-19, 2011; Washington DC, USA. [Oral Communication]

 

T. Chromecki, E.K. Cha, H. Fajkovic, S.F. Shariat Obesity adversely impacts disease specific outcomes in urothelial carcinoma of the urinary bladder
Journal of Men's Health . 2011; 8(3):216-217.-ISMH Congress 2011; Oct 2011; Vienna. [Oral Communication]

 

Chromecki, TF; Hutterer, GC; Zigeuner, R; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M; Mannweiler, S Tumour-associated macrophages are a favourable prognostic indicator in patients with papillary renal cell carcinoma
Eur Urol Suppl2010; 9(2):119-119.-25th Anniversary EAU (European Association of Urology) Congress; 16-20 April 2010; Barcelona. [Poster]

 

Hutterer, GC; Chromecki, T; Zigeuner, R; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M; Mannweiler, S Tumour-associated macrophages are a favourable prognostic indicator in patients with papillary renal cell carcinoma
Abstract book of the VIII. Urological Alpe-Adria Meeting2010; -VIII. Urological Alpe-Adria Meeting; OCT 2, 2010; Zagreb, Croatia. [Oral Communication]

 

Hutterer, GC; Chromecki, T; Zigeuner, R; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M; Mannweiler, S Nachweis tumorassoziierter Makrophagen (TAM) als prognostisch günstiger Indikator bei Patienten mit papillärem Nierenzellkarzinom
Der Urologe2010; 49(1):36-36.-62. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 22-25, 2010; Düsseldorf, Deutschland. [Oral Communication]

 

Hutterer, GC; Chromecki, TF; Zigeuner, R; Mannweiler, S; Klatte, T; Kampel-Kettner, K; Pummer, K; Remzi, M External validation of a nomogram predicting disease-specific survival of patients with papillary renal cell carcinoma
Eur Urol Suppl2010; 9(2):117-117.-25th Anniversary EAU (European Association of Urology) Congress ; 16-20 April 2010; Barcelona. [Poster]

 

Marszalek, M; Chromecki, T; Mohamad Al-Ali, B; Meixl, H; Madersbacher, S; Jeschke, K; Pummer, K; Zigeuner, R Endoscopic Partial Nephrectomy: Matched Pair Comparative Analysis of Transperitoneal and Retroperitoneal Approach
European Urology Supplements2010; 9(2):185-186.-25th Anniversary EAU Congress; 16-20 April 2010; Barcelona/spain. [Poster]

 

Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Stage migration of renal cell carcinoma in a European single centre over 23 years: Impact on survival
European Urology Supplements2009; 8(4):156-156.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. [Poster]
Web of Science

 

Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarkomatoide Transformation und Nierenbeckeneinbruch: Unabhängige Prognosefaktoren beim Nierenzellkarzinom?
Der Urologe Suppl.2009; 48: 121-121.-61. Kongress der Deutschen Gesellschaft für Urologie; SEP 16-19, 2009; Dresden, GERMANY. [Oral Communication]

 

Chromecki, T; Hutterer, GC; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R The Leibovich - mayo clinic scoring algorithm for clear cell renal cell carcinoma supplemented by vascular invasion
European Urology Supplements2009; 8(4):154-154.-24th Annual EAU Congress; MAR 17-21, 2009; Stockholm, SWEDEN. [Poster]
Web of Science

 

Marszalek, M; Chromecki, T; Meixl, H; Mohamad-Al-Ali, B; Madersbacher, SE; Jeschke, K; Pummer, K; Zigeuner, R Elektive laparoskopische Nierenteilresektion an zwei Zentren: Vergleich von transperitoealem und retroperitonealem Zugang anhand einer Matched-Pair-Analyse
Der Urologe Suppl.2009; 48: 116-116.-61. Kongress der Deutschen Gesellschaft für Urologie; SEP 19-19, 2009; Dresden, GERMANY. [Oral Communication]

 

Marszalek, M; Mohamad Al-Ali, B; Meixl, H; Chromecki, T; Madersbacher, S; Pummer, K; Jeschke, K; Zigeuner, R Elektive laparoskopische Nierenteilresektion an zwei Zentren: Vergleich von transperitonealem und retroperitonealem Zugang anhand einer matched-pair-Analyse.
Journal für Urologie und Urogynäkologie2009; 16(2):36-37.-35. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und der Bayrischen Urologenvereinigung; JUN 18-20, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Mohamad Al-Ali, B; Chromecki, T; Pummer, K; Trummer, H Korrelation zwischen klinischen Parametern und Spermiogramm von 716 Varikozelenpatienten.
Journal für Urologie und Urogynäkologie in Klinik und Praxis2009; 46-46.-35.Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayerischen Urologenvereinigung.; JUN 18-20, 2009; Salzburg, AUSTRIA. [Poster]

 

Mohamad Al-Ali, B; Chromecki, T; Pummer, K; Trummer, H Korrelation zwischen klinischen Parametern und Spermiogramm von 716 Varikozelenpatienten.
Der Urologe Supp2009; 48: 59-59.-61 Kongress der DGU; SEP 16-19, 2009; Dresden, GERMANY. [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External validation of the Leibovich scoring algorithm for clear cell renal cell carcinoma by a single European center applying routine pathology.
Proceedings book of the 2009 Genitourinary Cancers Symposium2009; 239-239.-2009 Genitourinary Cancers Symposium: A Multidisciplinary Approach; FEB 26-28, 2009; Orlando, FL, USA. (ISBN: 978-1-932312-70-6 ) [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K Prognostic impact of macroscopic and microscopic vascular tumor invasion in patients with clear cell renal cell carcinoma.
Proceedings book of the 2009 Genitourinary Cancers Symposium2009; 248-248.-2009 Genitourinary Cancers Symposium: A Multidisciplinary Approach; FEB 26-28, 2009; Orlando, FL, USA. (ISBN: 978-1-932312-70-6 ) [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Pummer, K Macroscopic versus microscopic vascular tumour invasion in patients with clear cell renal cell carcinoma: Does it make a difference?
J CLIN ONCOL. 2009; 27(15): 5093 - ASCO Annual Meeting; MAY 29-JUN 3, 2009; Orlando, FL, USA. [Poster]
Web of Science

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Stage Migration des Nierenzellkarzinoms und dessen Einfluß auf das Überleben: eine österreichische Single-Center-Studie über einen Zeitraum von 23 Jahren.
J Urol Urogynäkol 2008;15:38.2008; -34. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie ; 29-31 Mai 2008; Bamberg, Germany. [Oral Communication]

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarcomatoid transformation and collecting system invasion: Independent prognostic indicators in patients with renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):133-133.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. [Poster]
Web of Science

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Is the late occurrence of metastases associated with prolonged survival in renal cell carcinoma?
EUR UROL SUPPL. 2008; 7(3):260-260.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. [Poster]
Web of Science

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Ergänzung des Mayo-Clinic-Scoring-Algorithmus (MCSA) für das klarzellige Nierenzellkarzinom (NZK) durch Gefäßinvasion.
J Urol Urogynäkol 2008;15:23.2008; -34. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; 29-31 Mai 2008; Bamberg, Germany. [Poster]

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Ergänzung des Mayo Clinic Scoring Algorithmus (MCSA) für das klarzellige Nierenzellkarzinom (NZK) durch Gefäßinvasion.
Der Urologe 2008;Suppl 1:93.2008; -60. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 24-27, 2008; Stuttgart, Germany. [Oral Communication]

 

Chromecki, T; Hutterer, G; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Ist die späte Metastasierung bei Nierenzellkarzinompatienten assoziiert mit verlängertem Überleben?
Der Urologe 2008;Suppl 1:13.2008; -60. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 24-27, 2008; Stuttgart, Germany. [Poster]

 

Chromecki, T; Hutterer, G; Kampel-Kettner, K; Imamovic, A; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Sarcomatoid transformation and collecting system invasion: independent prognostic indicators in patients with renal cell carcinoma? J Urol Suppl 2008;179(4):415
American Urological Association (AUA) Annual Meeting, Orlando, FL, 17-22 May 2008; [Poster]

 

Chromecki,T; Hutterer, G; Kampel-Kettner, K; Imamovic, A; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Is late occurrence of metastases associated with prolonged survival in patients with renal cell carcinoma? J Urol Suppl 2008;179(4):414
J Urol Suppl 2008;179(4)2008; 414-414.-American Urological Association (AUA) Annual Meeting, ; MAY 17-22, 2008; Orlando, FL, USA. [Poster]

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Tumour necrosis: An independent prognostic indicator for clear cell, as well as papillary renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):135-135.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. [Poster]
Web of Science

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Macrovascular vs. Microvascular tumour invasion in patients with renal cell carcinoma: Does it make a difference ?
EUR UROL SUPPL. EUROPEAN UROLOGY SUPPLEMENTS 2008; 7(3):134-134.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. [Poster]
Web of Science

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Makro- vs. mikrovaskuläre Tumorinvasion bei Patienten mit Nierenzellkarzinom: Gibt es prognostische Unterschiede?
J Urol Urogynäkol 2008;15:24. 2008; -34. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; 29-31 Mai 2008; Bamberg, Germany. [Poster]

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Makro- vs. mikrovaskuläre Tumorinvasion bei Patienten mit Nierenzellkarzinom: Gibt es prognostische Unterschiede?
Der Urologe 2008;Suppl 1:92.2008; -60. Kongress der Deutschen Gesellschaft für Urologie e.V. ; 24-27 Sep 2008; Stuttgart. [Oral Communication]

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Histopathologischer Nachweis der Tumornekrose als unabhängiger Prognosefaktor bei klarzelligem und papillärem Nierenzellkarzinom.
J Urol Urogynäkol 2008;15:24. 2008; -34. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; 29-31 Mai 2008; Bamberg, Germany. [Poster]

 

Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K; Zigeuner, R Externe Validierung des ‘Leibovich’-Mayo Clinic Berechnungsalgorithmus für das klarzellige Nierenzellkarzinom in einer Single-Center Serie mittels Routine Pathologie
Der Urologe 2008;Suppl 1:93.2008; -60. Kongress der Deutschen Gesellschaft für Urologie e.V.; 24-27 Sep 2008; Stuttgart. [Oral Communication]

 

Hutterer, G; Zigeuner, R; Chromecki, T; Kampel-Kettner, K; Imamovic, A; Langner, C; Rehak, P; Pummer, K Externe Validierung des Mayo Clinic SSIGN score für das klarzellige Nierenzellkarzinom in einer österreichischen Single-Center Serie mittels Routine-Pathologie
Der Urologe 2008;Suppl 1:12.2008; -60. Kongress der Deutschen Gesellschaft für Urologie e.V.; 24-27 Sep 2008; Stuttgart. [Poster]

 

Karakiewicz, PI; Hutterer, GC; Suardi, N; Chromecki, T; Jeldres, C; Kampel-Kettner, K; Innamovic, A; Zigeuner, R; Bensaleh, K; Avakian, R; Shariat, SF; Montorsi, F; Perrotte, P; Patard, JJ Nomogram predicting renal cancer-specific survival in surgically treated patients with metastatic renal cell carcinoma
EUR UROL SUPPL. 2008; 7(3):282-282.-23rd Annual EAU (European Association of Urology) Congress; 26-29 March 2008; Milan, Italy. [Poster]
Web of Science

 

Pachernegg, O; Chromecki Verbesserte Diagnostik von high risk Harnblasentumoren durch Fluoreszenz-Zystoskopie
Wissenschaftliche Gesellschaft der Ärzte in der Steiermark; APR 3, 2008; LKH Graz. 2008. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K Stage migration of renal cell carcinoma in a single European center from 1984-2006
European Intrarenal Surgery Society (EIRSS) Meeting 2008; OCT 30-NOV 1, 2008; Paris, FRANCE. 2008. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K Prognostic impact of microscopic and macroscopic vascular invasion in patients with clear cell renal cell carcinoma.
European Intrarenal Surgery Society (EIRSS) Meeting 2008; OCT 30-NOV 1, 2008; Paris, FRANCE. 2008. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Imamovic, A; Kampel-Kettner, K; Rehak, P; Langner, C; Pummer, K External Validation of the Mayo Clinic SSIGN- and ‘Leibovich’ - scores for clear cell renal cell by a single European center applying routine pathology.
European Intrarenal Surgery Society (EIRSS) Meeting 2008; OCT 30-NOV 1, 2008; Paris, FRANCE. 2008. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Kampel-Kettner, K; Imamovic, A; Langner, C; Rehak, P; Pummer, K The mayo clinic stage, size, grade and necrosis (SSIGN) score for clear cell renal cell carcinoma: External validation by a single European centre applying routine pathology
EUR UROL SUPPL. 2008; 7(3):280-280.-23rd Annual EAU (European Association of Urology) Congress; MAR 26-29, 2008; Milan, Italy. [Poster]
Web of Science

 

Zigeuner, R; Hutterer, G; Chromecki, T; Langner, C; Rehak, P; Pummer, K The Mayo Clinic stage, size, grade, and necrosis (SSIGN) score for clear cell renal cell carcinoma: external validation by a single European center applying routine pathology.
Proceedings book of the 2008 genitourinary cancers symposium2008; 291-291.-2008 ASCO Genitourinary Cancers Symposium; FEB 14-16, 2008; San Francisco, CA, USA. (ISBN: 978-1-932312-50-8 ) [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C; Pummer, K Stage migration of renal cell carcinoma in a European single center over 23 years and its impact on survival.
Proceedings book of the 2008 Genitourinary Cancers Symposium2008; 292-292.-2008 ASCO Genitourinary Cancers Symposium ; FEB 14-16, 2008; San Francisco, CA, USA. (ISBN: 978-1-932312-50-8 ) [Poster]

 

Chromecki, T; Zigeuner, R; Hutterer, G; Rehak, P; Langner, C Ist eine Subklassifikation des Stadiums pT3 beim Urothelkarzinom des Nierenbeckens sinnvoll?
http://www.urologenportal.de/index.php?id=113&frame=abs07; P klin 4.4; 2007; -59. Kongreß der Deutschen Gesellschaft für Urologie; SEP 26-29, 2007; Berlin, GERMANY. [Poster]

 

Chromecki, T; Zigeuner, R; Hutterer, G; Rehak, P; Langner, C Invasionsmuster als Prognosefaktor bei Urothelkarzinomen des oberen Harntraktes
http://www.urologenportal.de/index.php?id=113&frame=abs07; P exp 2.15; 2007; -59. Kongreß der Deutschen Gesellschaft für Urologie; SEP 26-29, 2007; Berlin, GERMANY. [Poster]

 

Chromecki, T; Zigeuner, R; Rehak, P; Langner, C Die biologische Bedeutung von Fascin beim klarzelligen Nierenzellkarzinom.
J Urol Urogynäkol. 14 (Sonderheft 2), Abstrakt 1372007; 14(2):60-60.-33. Gemeinsame Tagung der Österreichischen Gesellschaft für Urologie und Andrologie und der Bayrischen Urologenvereinigung; JUN 14-16, 2007; Salzburg, AUSTRIA. [Oral Communication]

 

Riedler, I; Chromecki, Th; Hebel, P; Pummer, K Experience with percutaneous nephrolithotomy according to 400 procedures in Graz.
5th Urological Alpe-Adria Meeting; SEP 15, 2007; Verona, ITALY. 2007. [Oral Communication]

 

Zigeuner, R; Chromecki, T; Schips, L Autologer Fibrinkleber zur Blutstillung bei laparoskopischer Nierenteilresektion
http://www.urologenportal.de/index.php?id=113&frame=abs07; V 8.4; 2007; -59. Kongreß der Deutschen Gesellschaft für Urologie; SEP 26-29, 2007; Berlin GERMANY. [Oral Communication]

 

Zigeuner, R; Leibl, S; Rehak, P; Chromecki, T; Langner, C Desmoplasie ist ein unabhängiger prognostischer Parameter beim Urothelkarzinom des oberen Harntraktes
http://www.urologenportal.de/index.php?id=113&frame=abs07; P klin 4.2; 2007; -59. Kongreß der Deutschen Gesellschaft für Urologie; SEP 26-29, 2007; Berlin, GERMANY. [Poster]

 

Zigeuner, RE; Chromecki, T; Leibl, S; Rehak, P; Langner, C Desmoplasia is an independent prognostic indicator in urothelial carcinoma of the upper urinary tract
J UROL. 2007; 177(4):134-134.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Bladder tumor development after urothelial carcinoma of the upper urinary tract is related to primary tumor location
J UROL. 2007; 177(4):134-135.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

Zigeuner, RE; Chromecki, T; Rehak, P; Langner, C Cox-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-133.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

Zigeuner, RE; Chromecki, T; Winkler, A; Rehak, P; Langner, C CD24 expression in urothelial carcinoma of the upper urinary tract correlates with tumor progression
J UROL. 2007; 177(4):132-132.-AUA annual meeting; MAY 19-24, 2007; Anaheim, CA, USA. [Poster]
Web of Science

 

Chromecki, T; Langner, C; Hutterer, G; Rehak, P; Zigeuner, R Die Angioinvasion beim Urothelkarzinom des oberen Harntraktes ist mit Tumorstadium und Grad assoziiert
Journal für Urologie und Urogynäkologie. 13(2):71-72.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006; Garmisch-Partenkirchen. [Oral Communication]

 

Chromecki, T; Langner, C; Hutterer, G; Rehak, P; Zigeuner, R Invasionsmuster als Prognosefaktor bei Urothelkarzinomen des oberen Harntraktes
Journal für Urologie und Urogynäkologie. 13(2):41-42.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006; Garmisch-Partenkirchen. [Poster]

 

Chromecki, T; Langner, C; Hutterer, G; Rehak, P; Zigeuner, R Prognostische Relevanz von plattenepithelialer und/oder glandulärer Differenzierung bei Urothelkarzinomen des oberen Harntraktes2
Journal für Urologie und Urogynäkologie. 13(2):42-42.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006; Garmisch-Partenkirchen, Germany. [Poster]

 

Chromecki, T; Zigeuner, R; Hutterer, G; Rehak, P; Langner, C Bladder tumor development after transitional cell carcinoma of the upper urinary tract is related to tumor location.
Urology. 68, suppl. 5A: 315-315.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Chromecki, T; Zigeuner, R; Hutterer, G; Rehak, P; Langner, C COX-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumour progression
Der Urologe. 45, suppl. 1: 18-18.-58. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 20-23, 2006; Hamburg, GERMANY. [Poster]

 

Chromecki, T; Zigeuner, R; Hutterer, G; Rehak, P; Langner, C COX-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumor progression
Urology. 68, suppl. 5A: 315-316.-28th Congress of the Société Internationale d´Urologie; NOV 12-16,2006; Cape Town, South Africa. [Poster]

 

Hutterer, G; Langner, C; Chromecki, T; Höfler, G; Rehak, P; Zigeuner, R Alpha-Methylacyl-CoA-Racemase- (AMACR/P504S) Protein-Expression bei Urothelkarzinomen des oberen Harntraktes korreliert mit Tumorprogression
Journal für Urologie und Urogynäkologie. 13(2):43-43.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006 ; Garmisch-Partenkirchen, Germany. [Poster]

 

Hutterer, G; Langner, C; Chromecki, T; Rehak, P; Zigeuner, R Ist eine Subklassifikation des Stadiums pT3 beim Urothelkarzinom des Nierenbeckens sinnvoll?
Journal für Urologie und Urogynäkologie. 13(2):41-41.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006; Garmisch-Partenkirchen, Germany. [Poster]

 

Hutterer, G; Langner, C; Chromecki, T; Winkelmayer, I; Rehak, P; Zigeuner, R Vergleich des WHO-1973-Grading-Systems mit der WHO/ISUP Consensus-Klassifikation bei Urothelkarzinomen des oberen Harntraktes im Hinblick auf die Prognose
Journal für Urologie und Urogynäkologie. 13(2):41-41.-32. Gemeinsame Tagung der Bayerischen Urologenvereinigung und der Österreichischen Gesellschaft für Urologie und Andrologie; May 11-13, 2006; Garmisch-Partenkirchen, Germany. [Poster]

 

Hutterer, G; Zigeuner, R; Chromecki, T; Leibl, S; Rehak, P; Langner, C Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract
Urology. 68, suppl. 5A: 314-314.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Hutterer, G; Zigeuner, R; Chromecki, T; Rehak, P; Langner, C Biological significance of squamous and glandular differentiation in urothelial cell carcinoma of the upper urinary tract
Urology. 68, suppl. 5A: 314-315.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Hutterer, G; Zigeuner, R; Leibl, S; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology.
Der Urologe. 45, suppl. 1: 19-19.-58. Kongress der Deutschen Gesellschaft für Urologie e.V.; SEP 20-23, 2006; Hamburg, GERMANY. [Poster]

 

Langner, C; Hutterer, G; Chromecki, T; Leibl, P; Rehak, P; Zigeuner, R Tumour necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract
European Urology Supplements. 5(2):137-137.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Oral Communication]

 

Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Is the new-tiered WHO/ISUP grading system superior to the traditional three-tiered grading system in predicting outcome of patients with upper urinary tract urothelial carcinoma?
European Urology Supplements. 5(2):137-137.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Oral Communication]

 

Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Subdivision of stage pT3 in urothelial carcinoma of the renal pelvis facilitates detection of patients at high risk for failure
European Urology Supplements. 5(5):226-226.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Poster]

 

Langner, C; Hutterer, G; Chromecki, T; Rehak, P; Zigeuner, R Cox-2 expression in urothelial carcinomas of the upper urinary tract correlates with tumour progression
European Urology Supplements. 5(2):225-225.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Poster]

 

Leibl, S; Rupar, G; Zigeuner, R; Hutterer, C; Chromecki, T; Höfler, G; Rehak, P; Langner, C Alpha-methylacyl-CoA racemase (MACR/p504s) protein expression in urothelial carcinoma of the upper urinary tract corrrelates with tumour progression.
Pathol Res Pract. 202: 334-335.-90. Jahrestagung der Deutschen Gesellschaft für Pathologie; APR 19-21,2006; Berlin, GERMANY. [Poster]

 

Leibl, S; Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR-expression in urothelial carcinomas of the upper urinary tract: detection of a histologic subtype which might benefit from EGFR-targeted therapy.
Pathol Res Pract. 202: 335-335.-90. Jahrestagung der Deutschen Gesellschaft für Pathologie; APR 19-21,2006; Berlin, GERMANY. [Poster]

 

Leibl, S; Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Tumour necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract
Pathol Res Pract. 202: 290-291.-90. Jahrestagung der Deutschen Gesellschaft für Pathologie; APR 19-21; Berlin, GERMANY. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
Urological Alpe-Adria Meeting; SEP 15-16, 2006; Graz, Austria. 2006. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumour necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
23rd Meeting of the European Intrarenal Surgery Society (EIRSS); SEP 7-9, 2006; Heilbronn, GERMANY. 2006. [Oral Communication]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology
Urology. 68, suppl. 5A: 314-314.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
Urology. 68, suppl. 5A: 251-251.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Subdivision of Stage pT-3 in urothelial carcinoma of the renal pelvis facilitates detection of patients at high risk for failure
Urology. 68, suppl. 5A: 313-314.-28th Congress of the Société Internationale d´Urologie; NOV 12-16, 2006; Cape Town, South Africa. [Poster]

 

Zigeuner, R; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Biological significance of squamous and glandular differentiation in urothelial cell carcinoma of the upper urinary tract
European Urology Supplements. 5(2):136-136.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Oral Communication]

 

Zigeuner, R; Langner, C; Hutterer, G; Chromecki, T; Rehak, P Tumour necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract
-IV Urological Alpe-Adria Meeting; SEP 16, 2006; Graz, AUSTRIA. [Oral Communication]

 

Zigeuner, R; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract is associated with disease progression and metaplastic morphology
European Urology Supplements. 5(2):225-225.-Annual Congress of the European Association of Urology (EAU); April 5-8, 2006; Paris, France. [Poster]

 

Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Tumor necrosis as prognostic indicator in urothelial carcinoma of the upper urinary tract.
J UROL. 175: 351-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. [Poster]
Web of Science

 

Zigeuner, RE; Hutterer, G; Chromecki, T; Leibl, S; Rehak, P; Langner, C Impact of tumor stage, tumor grade, and vascular invasion on metastasis-free survival of patients with urothelial carcinoma of the upper urinary tract.
J UROL. ; 175: 352-352.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. [Poster]
Web of Science

 

Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C Alpha-methylacyl-CoA racemase (AMACR/P504S) protein expression in urothelial carcinoma of the upper urinary tract correlates with tumour progression
J UROL. 2006; 175: 132-132.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. [Poster]
Web of Science

 

Zigeuner, RE; Leibl, S; Hutterer, G; Chromecki, T; Rehak, P; Langner, C EGFR expression in urothelial carcinoma of the upper urinary tract correlates with disease progression and metaplastic morphology
J UROL. ; 175: 239-239.-AUA Annual Meeting; May 20-25, 2006; Atlanta, Georgia. [Poster]
Web of Science

 

Zigeuner, R; Chromecki, T; Lipsky, K; Petritsch, P Das niedrig differenzierte Blasenkarzinom beim älteren Patienten: Eine therapeutische Herausforderung.
Wissenschaftliche Sitzung der wissenschaftlichen Gesellschaft der Ärzte in der Steiermark.; MAR 10, 2005; Graz, Austria. 2005. [Oral Communication]

 

© Meduni Graz Impressum